Budesonide Te Arai controlled-release capsules is indicated for the treatment of Crohn's disease. (1)

​

Budesonide Te Arai is Fully funded from 1 November 2023. (2) 

 

Te Arai BioFarma is proud to be the first generic budesonide 3mg medicine to be funded in New Zealand. 

​